Viewing Study NCT02353468


Ignite Creation Date: 2025-12-24 @ 6:30 PM
Ignite Modification Date: 2026-02-21 @ 1:35 AM
Study NCT ID: NCT02353468
Status: TERMINATED
Last Update Posted: 2015-03-09
First Post: 2015-01-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
Sponsor: University of Colorado, Denver
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Plasma Cell Myeloma View
Keywords: